Vasculitis: Time of changes;Vascularites : Le temps des changements

Presse Medicale

Volumn 41, Issue 10, 2012, Pages 934-936

  Guillevin, Loïc ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HUMAN; PATHOGENESIS; VASCULITIS; WEGENER GRANULOMATOSIS; CARDIOVASCULAR SURGERY; CARDIOVASCULAR SYSTEM EXAMINATION; HISTORY; METHODOLOGY; REVIEW; TIME;

CARDIOVASCULAR SURGICAL PROCEDURES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; TIME FACTORS; VASCULITIS;

EID: 84866429347     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.07.009     Document Type: Editorial

References (22)

1. Küssmaul A., Maier R. Ueber eine bischer nicht beschreibene eigenthumliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellhamung einhergeht. Dtsch Arch Klin Med 1866, 1:484-518.
2. Wohlwill F. Ueber die nur mikroskopisch erkennbare Form der Periarteritis nodosa. Virchows Arch Pathol Anat 1923, 246:377-411.
3. Wegener F. über generalisierte, septische Gefässerkrankungen. Vehandlungen des Deutschen Gesellschaft für Pathologie 1937, 29:202-208.
4. Wegener F. über eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems un der Nieren. Beiträge zur Pathologischen Anatomie 1939, 102:36-68.
5. Lightfoot R.W., Michel B.A., Bloch D.A., Hunder G.G., Zvaifler N.J., McShane D.J., et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990, 33(8):1088-1093.
6. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33(8):1094-1100.
7. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., Arend W.P., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990, 33(8):1101-1107.
8. Hunder G.G., Arend W.P., Bloch D.A., Calabrese L.H., Fauci A.S., Fries J.F., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990, 33(8):1065-1067.
9. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., Gross W.L., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37(2):187-192.
10. Trepo C., Thivolet J. Hepatitis associated antigen and periarteritis nodosa (PAN). Vox Sang 1970, 19(3):410-411.
11. Trepo C., Thivolet J. Antigène Australia, virus de l'hépatite et périartérite noueuse. Presse Med 1970, 78(36):1575.
12. Pascual M., Perrin L., Giostra E., Schifferli J. Hepatitis C in patients with cryoglobulinemia type II. J Infect Dis 1990, 162:569-570.
13. van der Woude F.J. Anticytoplasmic antibodies in Wegener's granulomatosis. Lancet 1985, 2(8445):48.
14. van der Woude F.J., Rasmussen N., Lobatto S., Wiik A., Permin H., van Es L.A., et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985, 1(8426):425-429.
15. Fauci A.S., Wolff S.M., Johnson J.S. Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis. N Engl J Med 1971, 285(27):1493-1496.
16. Frohnert P.P., Sheps S.G. Long-term follow-up study of periarteritis nodosa. Am J Med 1967, 43(1):8-14.
17. Guillevin L., Lhote F., Cohen P., Sauvaget F., Jarrousse B., Lortholary O., et al. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995, 74(5):238-253.
18. Sable-Fourtassou R., Cohen P., Mahr A., Pagnoux C., Mouthon L., Jayne D., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 2005, 143(9):632-638.
19. Sinico R.A., Di Toma L., Maggiore U., Bottero P., Radice A., Tosoni C., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52(9):2926-2935.
20. Lyons P.A., Rayner T.F., Trivedi S., Holle J.U., Watts R.A., Jayne D.R., et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012, 367(3):214-223.
21. Stone J.H., Merkel P.A., Spiera R., Seo P., Langford C.A., Hoffman G.S., et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 2010, 363(3):221-232.
22. Martinez V., Cohen P., Pagnoux C., Vinzio S., Mahr A., Mouthon L., et al. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients. Arthritis Rheum 2008, 58(1):308-317.